These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 23325103)
41. Antidiabetic activity of Mohanty IR; Kumar CS; Borde M Indian J Pharmacol; 2021; 53(5):384-387. PubMed ID: 34854407 [TBL] [Abstract][Full Text] [Related]
42. Identification and molecular docking study of sugarcane leaf-derived compounds as potent dipeptidyl peptidase IV, α-glucosidase, and α-amylase inhibitors. Kan R; Ren P; Wu A; Tang Q; Kong B; Xue C J Sci Food Agric; 2023 Aug; 103(11):5388-5400. PubMed ID: 37038045 [TBL] [Abstract][Full Text] [Related]
43. Dipeptidyl peptidase IV inhibitory peptides generated in Spanish dry-cured ham. Gallego M; Aristoy MC; Toldrá F Meat Sci; 2014 Feb; 96(2 Pt A):757-61. PubMed ID: 24200567 [TBL] [Abstract][Full Text] [Related]
44. Recent advances in non-peptidomimetic dipeptidyl peptidase 4 inhibitors: medicinal chemistry and preclinical aspects. Liu Y; Hu Y; Liu T Curr Med Chem; 2012; 19(23):3982-99. PubMed ID: 22709010 [TBL] [Abstract][Full Text] [Related]
45. The dipeptidyl peptidase-4 inhibitory effect of flavonoids is hindered in protein rich environments. Proença C; Freitas M; Ribeiro D; Tomé SM; Araújo AN; Silva AMS; Fernandes PA; Fernandes E Food Funct; 2019 Sep; 10(9):5718-5731. PubMed ID: 31441917 [TBL] [Abstract][Full Text] [Related]
46. Model Optimization and In Silico Analysis of Potential Dipeptidyl Peptidase IV Antagonists from GC-MS Identified Compounds in Iheagwam FN; Ogunlana OO; Chinedu SN Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775302 [TBL] [Abstract][Full Text] [Related]
47. Synthesis, structure-activity relationship, and pharmacophore modeling studies of pyrazole-3-carbohydrazone derivatives as dipeptidyl peptidase IV inhibitors. Wu D; Jin F; Lu W; Zhu J; Li C; Wang W; Tang Y; Jiang H; Huang J; Liu G; Li J Chem Biol Drug Des; 2012 Jun; 79(6):897-906. PubMed ID: 22381062 [TBL] [Abstract][Full Text] [Related]
48. Chemical characterization and biological activity of Chaga (Inonotus obliquus), a medicinal "mushroom". Glamočlija J; Ćirić A; Nikolić M; Fernandes Â; Barros L; Calhelha RC; Ferreira IC; Soković M; van Griensven LJ J Ethnopharmacol; 2015 Mar; 162():323-32. PubMed ID: 25576897 [TBL] [Abstract][Full Text] [Related]
49. Combined Ligand-Based and Structure-Based Virtual Screening Approach for Identification of New Dipeptidyl Peptidase 4 Inhibitors. Upadhyay J; Gajjar A; Suhagia BN Curr Drug Discov Technol; 2019; 16(4):426-436. PubMed ID: 30255759 [TBL] [Abstract][Full Text] [Related]
50. Peptides Derived from Soy and Lupin Protein as Dipeptidyl-Peptidase IV Inhibitors: In Vitro Biochemical Screening and in Silico Molecular Modeling Study. Lammi C; Zanoni C; Arnoldi A; Vistoli G J Agric Food Chem; 2016 Dec; 64(51):9601-9606. PubMed ID: 27983830 [TBL] [Abstract][Full Text] [Related]
51. Identification of angiotensin converting enzyme and dipeptidyl peptidase-IV inhibitory peptides derived from oilseed proteins using two integrated bioinformatic approaches. Han R; Maycock J; Murray BS; Boesch C Food Res Int; 2019 Jan; 115():283-291. PubMed ID: 30599943 [TBL] [Abstract][Full Text] [Related]
52. Dual Glycation-Inflammation Modulation, DPP-IV and Pancraetic Lipase Inhibitory Potentials and Antiproliferative Activity of Novel Fluoroquinolones. Arabiyat S; Kasabri V; Al-Hiari Y; Al-Masri I; Alalawi S; Bustanji Y Asian Pac J Cancer Prev; 2019 Aug; 20(8):2503-2514. PubMed ID: 31450926 [TBL] [Abstract][Full Text] [Related]
53. Chemical Composition and Inhibitory Effects of Hypericum brasiliense and H. connatum on Prolyl Oligopeptidase and Acetylcholinesterase Activities. Dos Santos MZ; Dalcol II; Adolpho L; Teixidó M; Tarragó T; Morel A; Giralt E Med Chem; 2016; 12(5):457-63. PubMed ID: 26497127 [TBL] [Abstract][Full Text] [Related]
54. Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (part I): virtual screening and activity assays. Guasch L; Ojeda MJ; González-Abuín N; Sala E; Cereto-Massagué A; Mulero M; Valls C; Pinent M; Ardévol A; Garcia-Vallvé S; Pujadas G PLoS One; 2012; 7(9):e44971. PubMed ID: 22984596 [TBL] [Abstract][Full Text] [Related]
56. Surrogating and redirection of pyrazolo[1,5-a]pyrimidin-7(4H)-one core, a novel class of potent and selective DPP-4 inhibitors. Deng X; Shen J; Zhu H; Xiao J; Sun R; Xie F; Lam C; Wang J; Qiao Y; Tavallaie MS; Hu Y; Du Y; Li J; Fu L; Jiang F Bioorg Med Chem; 2018 Feb; 26(4):903-912. PubMed ID: 29373269 [TBL] [Abstract][Full Text] [Related]
57. Synthesis, Structural Characterization and Docking Studies of Sulfamoyl- Phenyl Acid Esters as Dipeptidyl Peptidase-IV Inhibitors. Khalaf RA; Sabbah D; Al-Shalabi E; Al-Sheikh I; Albadawi G; Abu Sheikha G Curr Comput Aided Drug Des; 2018; 14(2):142-151. PubMed ID: 29521244 [TBL] [Abstract][Full Text] [Related]
58. Structure-based virtual screening of dipeptidyl peptidase 4 inhibitors and their in vitro analysis. Rahman SU; Ali HS; Jafari B; Zaib S; Hameed A; Al-Kahraman YMSA; Langer P; Iqbal J Comput Biol Chem; 2021 Apr; 91():107326. PubMed ID: 32739275 [TBL] [Abstract][Full Text] [Related]
59. Synthesis and characterization of oxidovanadium complexes as enzyme inhibitors targeting dipeptidyl peptidase IV. Xie MJ; Zhu MR; Lu CM; Jin Y; Gao LH; Li L; Zhou J; Li FF; Zhao QH; Liu HK; Sadler PJ; Sanchez-Cano C J Inorg Biochem; 2017 Oct; 175():29-35. PubMed ID: 28692886 [TBL] [Abstract][Full Text] [Related]
60. Discovery of potent, selective, and orally bioavailable quinoline-based dipeptidyl peptidase IV inhibitors targeting Lys554. Maezaki H; Banno Y; Miyamoto Y; Moritoh Y; Asakawa T; Kataoka O; Takeuchi K; Suzuki N; Ikedo K; Kosaka T; Sasaki M; Tsubotani S; Tani A; Funami M; Yamamoto Y; Tawada M; Aertgeerts K; Yano J; Oi S Bioorg Med Chem; 2011 Aug; 19(15):4482-98. PubMed ID: 21741847 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]